Results 91 to 100 of about 24,300 (246)

CHRONIC LUNG ALLOGRAFT DYSFUNCTION ACCELERATED BY RECURRENT VIRAL INSULTS [PDF]

, 2023
DEEPIKA RAZIA, BHUVIN M BUDDHDEV, Hesham Mohamed, ASHWINI ARJUNA   +3 more
openalex   +1 more source

Exploring the immunomodulatory impacts of blood manufacturing consolidation

Transfusion, EarlyView.
Abstract Introduction The immunomodulatory consequences of blood transfusion, known as transfusion‐related immune modulation (TRIM), are often not captured by hemovigilance systems. Changes to blood product manufacturing processes may impact patient outcomes.
Amanda Kauffman, Michelle P. Zeller, Yang Liu, Jason P. Acker, Donald M. Arnold, Nancy Heddle, Chris Hillis, Na Li, Bram Rochwerg, Kayla Lucier, Summer Syed, Shuoyan Ning   +11 more
wiley   +1 more source

Lung transplantation in cystic fibrosis: Trends and controversies [PDF]

, 2015
This article is not an overview of all facets of lung transplantation in cystic fibrosis (CF), but rather it is intended as a review of current allocation controversies, as well as of trends in diagnostics and management in lung transplant recipients and
Blatter, Joshua, Sweet, Stuart
core   +2 more sources

Risk Assessment of Chronic Lung Allograft Dysfunction Phenotypes after Living-Donor Lobar Lung Transplantation According to the 2019 ISHLT Classification System [PDF]

, 2021
K. Matsubara, Shinji Otani, Dai Shimizu, Yasuaki Tomioka, Toshio Shiotani, Hiroshi Yamamoto, Kentaroh Miyoshi, Mikio Okazaki, Seiichiro Sugimoto, Masaomi Yamane, Shinichi Toyooka   +10 more
openalex   +1 more source

Takotsubo Cardiomyopathy Secondary to Lung Transplantation Followed by Reduced Ejection Fraction Heart Failure: A Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
A 23‐year‐old male with cystic fibrosis developed Takotsubo cardiomyopathy with left ventricular reduced ejection fraction during bilateral lung transplantation. One year later, he presented with reduced left ventricular ejection fraction and pulmonary edema in the context of medication non‐adherence.
Azadeh Moradkhani, Masoume Avateffazeli, Farah Naghashzadeh, Salman Soleimani, Zargham Hossein Ahmadi, Alireza Jahangiri Fard, Sina Homaee, Mohammad Varahram, Mahshid Hajiali, Shadi Shafaghi, Atefeh Abedini   +10 more
wiley   +1 more source

Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres

Frontiers in Immunology, 2020
Alemtuzumab, a monoclonal antibody targeting CD52 that causes lymphocyte apoptosis, is a form of advanced immunosuppression that is currently used as a therapy for refractory acute cellular rejection and chronic lung allograft dysfunction in lung ...
Anil J. Trindade, Anil J. Trindade, Anil J. Trindade, Tany Thaniyavarn, Tany Thaniyavarn, Keri Townsend, Robin Klasek, Karen P. Tsveybel, John C. Kennedy, John C. Kennedy, Hilary J. Goldberg, Hilary J. Goldberg, Souheil El-Chemaly, Souheil El-Chemaly   +13 more
doaj   +1 more source

Impaired Esophageal Motility and Clearance Post-Lung Transplant: Risk For Chronic Allograft Failure [PDF]

, 2017
Objectives: Gastroesophageal reflux is common in patients post-lung transplantation (LTx) and thus considered a risk factor for aspiration and consequently allograft rejection and the development of chronic allograft failure. However, evidence supporting
Almansa, Atkins, Atkins, Blondeau, Cantu, Davis, Davis, Davis, DOvidio, DOvidio, Fisichella, Fisichella, Frazzoni, Frazzoni, Griffin, Hadjiliadis, Johnson, Kahrilas, Mendez, Meyer, Pegna, Ribolsi, Robertson, Roman, Sato, Shay, Stovold, Tutuian, Verleden, Ward, Young   +30 more
core   +1 more source

Crucial Contribution of BACH1 to Bladder Cancer Progression via Upregulating Epithelial‐Mesenchymal Transition Pathway

Cancer Science, Volume 117, Issue 2, Page 364-376, February 2026.
BACH1 is associated with poor prognosis in BC patients and plays a critical role in promoting tumor progression and metastasis. Furthermore, we elucidated the mechanism by which BACH1 facilitates tumor progression and metastasis, primarily through activation of the EMT pathway. These findings suggest that BACH1 may serve as a novel prognostic biomarker
Tomoya Hatayama, Kenshiro Takemoto, Kohei Kobatake, Kento Miura, Liyanage P. Perera, Ryoken Yamanaka, Kazuma Yukihiro, Hiroyuki Shikuma, Kyosuke Iwane, Ryo Tasaka, Yuki Kohada, Miki Naito, Shunsuke Miyamoto, Yohei Sekino, Hiroyuki Kitano, Keisuke Goto, Akihiro Goriki, Keisuke Hieda, Osamu Kaminuma, Nobuyuki Hinata   +19 more
wiley   +1 more source

Alternative Measures of Body Composition and Outcomes Following Heart Transplant

Clinical Transplantation, Volume 40, Issue 2, February 2026.
ABSTRACT Current guidelines for heart transplant (HT) listing support body mass index (BMI) < 35 kg/m2, though data supporting this recommendation is mixed. It is unclear if other more specific measurements of body composition are better predictors of outcomes post‐HT.
Ana Lanier, Umar Siddiqi, Usmaan Siddiqi, Linda Lee, Seyed Ehsan Saffari, Mark Belkin, Jonathan Grinstein, Anthony Kanelidis, Leo Gozdecki, Stanley Swat, Sara Kalantari, Nitasha Sarswat, Bow Ben Chung, Gene Kim, Chris Salerno, Valluvan Jeevanandam, Manreet Kanwar, Ann Nguyen   +17 more
wiley   +1 more source

Clinical Characteristics and Long-term outcomes of patients undergoing combined heart-kidney transplantation: a single-center experience [PDF]

, 2015
[Abstract] Background. The purpose of the study was to describe clinical characteristics and long-term survival of patients undergoing combined heart-kidney transplant in a single center. Methods.
Alonso-Hernández, Á., Barge-Caballero, Eduardo, Crespo-Leiro, María Generosa, Fernández Arias, L., García-Vieites, M., López-Sainz, A., Marzoa Rivas, Raquel, Paniagua-Martín, María J., Rodríguez-Rivera-García, J.J., Sánchez-Fernández, G.   +9 more
core   +2 more sources